Skip to main content
Late-onset Becker muscular dystrophy: Refining the clinical features and electrophysiological findings.
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.
Peripheral muscle weakness in RASopathies.
Treatment of hypokalemic periodic paralysis with topiramate.
Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.